31 -2 (34) 2021 — Tojieva I.M., Khaydarova F.A., — COVID-19 AND ITS COMPLICATIONS

COVID-19 AND ITS COMPLICATIONS

Tojieva I.M., Republican Specialized Scientific and Practical Center of Endocrinology named by Y.H. Turakolov, Tashkent, Uzbekistan

Khaydarova F.A., Republican Specialized Scientific and Practical Center of Endocrinology named by Y.H. Turakolov, Tashkent, Uzbekistan

Alieva A.V., Republican Specialized Scientific and Practical Center of Endocrinology named by Y.H. Turakolov, Tashkent, Uzbekistan

Alimov A.V., Republican Specialized Scientific and Practical Center of Endocrinology named by Y.H. Turakolov, Tashkent, Uzbekistan

Alimova N.U. Republican Specialized Scientific and Practical Center of Endocrinology named by Y.H. Turakolov, Tashkent, Uzbekistan

Resume

Coronavirus Disease 2019 (COVID-19), a severe acute respiratory infection caused by the SARS-CoV-2 coronavirus that is spreading rapidly around the world. The World Health Organization declared the outbreak a public health emergency of international concern and then a pandemic. Most of the complications of this disease occur due to viral invasion, in response to which the cells of the immune system produce anti-inflammatory cytokines and activate the coagulation cascade that leads to thrombosis. Changes in the affected organs occur not only in the acute period, but are also long-term, and therefore the long-term consequences of COVID-19 infections will be the focus of public health for many years after the infection subsides.

Key words: coronavirus, complications, coagulopathy, covid 19, SARS-CoV-2

First page

160

Last page

164

For citation: Tojieva I.M., Khaydarova F.A., Alieva A.V., Alimov A.V., Alimova N.U. Covid-19 and its complications//New Day in Medicine 2(34)2021 160-164 https://cutt.ly/HntrhAd

List of References

  1. ZaimS, ChongJH, SankaranarayananV, HarkyA. COVID-19and multi-organ response. Curr Probl Cardiol. 2020;45(8):100618
  2. Walitt B., Bartrumb E. A clinical primer for the expected and potential post-COVID-19 syndromes Pain Rep. 2021 Feb 16;6(1):e887. doi: 10.1097/PR9.0000000000000887
  3. Tang N, Li D, Wang X, Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. 2020;18:844-847.
  4. Merad M, Martin JC. Pathological inflammation in patients with COVID19: a key role for monocytes and macrophages. Nat Rev Immunol 2020; 20:355–62.
  5. Mucha SR, Dugar S, McCrae K, Joseph D, Bartholomew J, Sacha GL, MilitelloM.CoagulopathyinCOVID-19:manifestationsandmanagement. Cleve Clin J Med 2020;87:461–8.
  6. Poissy J, Goutay J, Caplan M, Parmentier E, Duburcq T, Lassalle F, Jeanpierre E, Rauch A, Labreuche J, Susen S, Lille ICUHCG. Pulmonary embolism in patients with COVID-19: awareness of an increased prevalence. Circulation 2020;142:184–6.
  7. Veyseh M, Pophali P, Jayarangaiah A, Kumar A. Left gonadal vein thrombosis in a patient with COVID-19-associated coagulopathy. BMJ Case Rep 2020;13
  8. Lago VC, Prudente RA, Luzia DA, et al. Persistent interstitial lung abnormalities in post-COVID-19 patients: a case series. J Venom Anim Toxins Incl Trop Dis. 2021;27:e20200157
  9. Giamarellos-Bourboulis EJ, Netea MG, Rovina N, Akinosoglou K, Antoniadou A, Antonakos N, et al. Complex immune dysregulation in COVID-19 patients with severe respiratory failure. Cell Host Microbe. 2020 Jun 10;27(6):992-1000.e3
  10. Spagnolo P, Balestro E, Aliberti S, Cocconcelli E, Biondini D, Casa GD, et al. Pulmonary fibrosis secondary to COVID-19: a call to arms? Lancet Respir Med. 2020 Aug;8(8):750-2.
  11. George PM, Barratt SL, Condliffe R, Desai SR, Devaraj A, Forrest I, et al. Respiratory follow-up of patients with COVID-19 pneumonia. Thorax. 2020;2020-215314. 
  12. Mo X, Jian W, Su Z, Chen M, Peng H, Peng P, et al. Abnormal pulmonary function in COVID-19 patients at time of hospital discharge. Eur Respir J. 2020 Jun;55(6):2001217, Frija-Masson J, Debray MP, Gilbert M, Lescure FX, Travert F, Borie R, et al. Functional characteristics of patients with SARS-CoV-2 pneumonia at 30 days post-infection. Eur Respir J. 2020 Aug;56(2):2001754
  13. Inciardi RM, Lupi L, Zaccone G, Italia L, Raffo M, Tomasoni D, et al. Cardiac involvement in a patient with coronavirus disease 2019 (COVID-19) JAMA cardiology. 2020
  14. Aghagoli G, Gallo Marin B, Soliman LB, Sellke FW. Cardiac involvement in COVID‐19 patients: Risk factors, predictors, and complications: A review. Journal of Cardiac Surgery. 2020 
  15. Wong S.H., Lui R.N., Sung J.J. Covid-19 and the digestive system. J. Gastroenterol. Hepatol. 2020 doi: 10.1111/jgh.15047.
  16. Tariq R, Saha S, Furqan F, Hassett L, Pardi D, Khanna S. Prevalence and mortality of COVID-19 patients with gastrointestinal symptoms: a systematic review and meta-analysis. Mayo Clin Proc 2020;95: 1632–48
  17. Anand ER, Major C, Pickering O, Nelson M. Acute pancreatitis in a COVID-19 patient. Br J Surg 2020;107:e182.
  18. Bruni A, Garofalo E, Zuccala V, Curro G, Torti C, Navarra G, De Sarro G, Navalesi P, Longhini F, Ammendola M. Histopathological findings in a COVID-19patientaffectedbyischemicgangrenouscholecystitis.WorldJ Emerg Surg 2020;15:43.
  19. Cheung S, Quiwa JC, Pillai A, Onwu C, Tharayil ZJ, Gupta R. Superior mesenteric artery thrombosis and acute intestinal ischemia as a consequence of COVID-19 infection. Am J Case Rep 2020;21:e925753
  20. The Centers for Disease Control and Prevention (CDC) Health Alert Network. Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with Coronavirus Disease 2019.https://emergency.cdc.gov/han/2020/han00432.asp

file

download